Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Rashid Latif Medical College

ClinicalTrials.gov lists Rashid Latif Medical College as lead sponsor of 14 trials. It has 8 active development programs and 3 approved assets.

PK Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

8 0 2020 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Rashid Latif Medical College: 14 lead-sponsored trials and 1 legal-entity registration.

Get the Rashid Latif Medical College report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (12)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 5
Pulmonary Disease, Chronic Obstructive 2
Anxiety Disorders 1
Back Pain 1
Chronic Inducible Urticaria 1

Showing 5 of 12 disease areas.

Start your 14-day trial Email me all 12 disease areas as a PDF

Trials by start year as sponsor or collaborator (4)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 3
2025 2
2024 8
2020 1

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (8)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Verapamil Injection Tachycardia Phase 3 1
Verapamil Injection Tachycardia, Supraventricular Phase 3 1
Adenosine Tachycardia Phase 3 1
Adenosine Tachycardia, Supraventricular Phase 3 1
Apremilast Chronic Urticaria Phase 2 1

Showing 5 of 8 active programs.

Start your 14-day trial Email me all 8 active programs as a PDF

Approved assets (3)

Shown in this order: max phase first.

Approved assets
Drug Trials
Adenosine 1
Apremilast 1
METFORMIN 1

Journals published in (29)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of bodywork and movement therapies 3
American journal of lifestyle medicine 1
BMC complementary medicine and therapies 1
BMC nephrology 1
BMC sports science, medicine & rehabilitation 1

Showing 5 of 29 journals.

Start your 14-day trial Email me all 29 journals as a PDF

Latest dated events (14)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09-23 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-16 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06-24 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-08-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-03-20 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 14 events.

Start your 14-day trial Email me all 14 events as a PDF

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
TKTL1 Trial sponsor Named in trial inclusion criteria
UFL1 Trial sponsor Named in trial inclusion criteria
NADK Trial sponsor Named in trial exclusion criteria
NADK Trial sponsor Mentioned in trial text
TKTL1 Trial sponsor Mentioned in trial text

Showing 5 of 6 evidence rows.

Start your 14-day trial Email me all 6 evidence rows as a PDF

Biomarkers this organization publishes on (7)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
F2 1
IL10 1
IL4 1
IL6 1
TGFB1 1

Showing 5 of 7 biomarkers.

Start your 14-day trial Email me all 7 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and clia clinical laboratory certificates.